Universal Health Services INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
Universal Health Services, Inc. has entered into an underwriting agreement to issue and sell $1.1 billion in senior secured notes across two tranches.
NYSE
Universal Health Services, Inc. announced its second quarter 2026 financial results, reporting increased net income and revenues, and provided a revised full-year operating forecast.
NYSE
Universal Health Services, Inc. has amended its credit agreement to add a new $700 million delayed draw term loan facility for general corporate purposes.
NYSE
Universal Health Services stockholders elected directors, approved executive compensation, and rejected a shareholder proposal at the 2026 Annual Meeting.
NYSE
Universal Health Services, Inc. announced the resignation of Matthew J. Peterson, Executive Vice President and President of Behavioral Health, effective June 19, 2026, with CEO Marc D. Miller to assume interim responsibilities.
NYSE
Universal Health Services, Inc. announced robust financial results for the first quarter of 2026, with net income and revenues showing significant year-over-year growth.
NYSE
Universal Health Services, Inc. has amended its credit agreement to increase its senior secured credit facility by up to $900 million, including new revolving and term loan facilities.
NYSE
Universal Health Services set 2026 executive bonus targets, awarded new RSUs/PBRSUs at $185.09, and raised PBRSU maximum payout to 200% using a new three-year average performance method.
NYSE
Universal Health Services, Inc. announced robust financial results for 2025, including significant revenue and earnings growth, and provided an optimistic 2026 forecast, while also securing a new trial in a major lawsuit that had initially awarded $500 million in punitive damages.
NYSE
Universal Health Services, Inc. announced an amended employment agreement for CEO Marc D. Miller, extending his term and increasing his 2026 base salary by 5% to $1,575,000.
NYSE
Universal Health Services, Inc. announced strong third-quarter 2025 financial results, raising its full-year operating forecast and increasing its stock repurchase program authorization by $1.5 billion.
NYSE
Universal Health Services' subsidiary, UHS of Delaware, Inc., was hit with a $500 million punitive damages verdict in a Nevada lawsuit, though the company expects a significant reduction.
NYSE
Universal Health Services, Inc. announced robust financial results for the second quarter and first half of 2025, driven by increased revenues and supplemental Medicaid reimbursements, leading to an upward revision of its full-year operating forecast.
NYSE
Universal Health Services held its 2025 Annual Meeting of Stockholders, electing two Class II members to the Board of Directors and ratifying PricewaterhouseCoopers as its independent accounting firm, while rejecting a proposal for annual director elections.
NYSE
Universal Health Services, Inc. (UHS) announced a significant increase in net income and revenues for the first quarter of 2025 compared to the same period in 2024, driven by growth in both acute care and behavioral health services.
NYSE
Universal Health Services (UHS) has updated employment agreements for key executives, including CEO Marc D. Miller and Executive Chairman Alan B. Miller, and approved 2025 incentive bonus plans.
NYSE
Universal Health Services (UHS) announces significant increases in net income and revenue for Q4 and full year 2024, alongside a promising 2025 operating results forecast.
NYSE
Universal Health Services, Inc. announced a significant increase in net income and revenue for the third quarter of 2024 compared to the same period last year.
NYSE
A subsidiary of Universal Health Services, the Pavilion Behavioral Health System, had its punitive damages reduced in a lawsuit, but still faces a significant judgment.
NYSE
Universal Health Services successfully completed a $1 billion offering of senior secured notes and amended its senior credit facility, enhancing its financial flexibility.
NYSE
Universal Health Services and its subsidiaries are facing substantial financial exposure due to adverse jury verdicts in two separate legal cases, with potential for material impact on future results.
NYSE
Universal Health Services, Inc. has successfully priced and will issue $1 billion in senior secured notes across two tranches to refinance existing debt and for general corporate purposes.
NYSE
8-K: Universal Health Services Boosts 2024 Outlook and Stock Buyback Program After Strong Q2 Results
Universal Health Services reported a significant increase in net income and revenue for the second quarter of 2024, leading to an increased full-year forecast and a $1 billion boost to its stock repurchase program.
NYSE
8-K: Universal Health Services Holds 2024 Annual Meeting, Elects Directors and Approves Incentive Plans
Universal Health Services held its 2024 Annual Meeting of Stockholders, where directors were elected, incentive plans were approved, and the company's auditor was ratified.
NYSE
Universal Health Services, Inc. announced a significant increase in net income and revenue for the first quarter of 2024 compared to the same period last year.
NYSE
A subsidiary of Universal Health Services, Pavilion Behavioral Health System, has been hit with a $535 million jury verdict in a sexual assault case.
NYSE
Universal Health Services has approved annual incentive bonuses and long-term stock awards for its executive officers based on corporate and divisional performance criteria for the year ending December 31, 2024.
NYSE
Universal Health Services issued an amended filing to correct inaccurate statistical information related to its behavioral health facilities for the three months ended December 31, 2023.
NYSE
Universal Health Services, Inc. announced a 7.4% increase in net revenues for the fourth quarter of 2023 and provided a positive outlook for 2024, including a projected revenue increase of 7.9% to 10.0%.